12:09 PM EST - Nventa Biopharmaceuticals Corp. : on Wednesday posted financial results for fiscal 2006, reporting a net loss of $10.07 million or $0.12 per share compared to a loss of $19.61 million or $0.27 per share in the previous year. The company reported a loss from continuing operations of $10.07 million or $0.12 per share compared to a loss of $27.07 million or $0.37 per share in the prior year. The results for the latest quarter were calculated on 83.44 million shares compared to 73.93 million shares in the previous year. Nventa Biopharmaceuticals Corp.
shares T.NVN are trading down 1 cent at $0.20.
